Proceeding contribution from Evan Harris (Liberal Democrat) in the House of Commons on Tuesday, 4 November 2008. It occurred during Ministerial statement on NHS Patients (Access to Medicines).
NHS Patients (Access to Medicines)
Does the Secretary of State accept that there are lots of unanswered questions? For example, how does he deal with the situation of an NHS consultant referring and recommending a private treatment given by himself in an NHS pay bed with the income going to that trust? How does he deal with the problem faced by someone who responds to a private treatment that keeps them alive but then runs out of money and finds that the drug is not allowed on the NHS because it worked for only a few people? Surely that treatment should then become payable by the NHS. Does he accept that more work needs to be done on those questions?
Secondary information
- Type
- Proceeding contribution
- Reference
- 482 c143
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Access Finance Fees and charges Drugs Private sector NHS Medical treatments Patients Payments National Institute for Health and Care Excellence Consequences of Additional Private Drugs for NHS Care Review
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:23:41 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505631
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505631
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505631